Malignant Psoas Syndrome: Recognition of an Oncologic Entity
Authors:
- 1 May 1990
- journal article
- case report
- Published by Wiley in Australasian Radiology
- Vol. 34 (2) , 150-154
Abstract
From January 1985 to January 1989 four patients with advanced cancer developed a syndrome characterized by proximal lumbosacral plexopathy and painful flexion of the ipsilateral hip with positive psoas muscle stretch test. Malignant involvement of the psoas major muscle was confirmed radiologically in all cases. Pain was intractable in 3 patients until time of death.We have termed this presentation the malignant psoas syndrome (MPS) and retrospective review of 427 oncology patients with “high risk” solid cancer culled no additional cases during the same 4–year period. We believe MPS to be a hitherto unreported complication of systemic cancer in which malignant involvement of the psoas muscle, in addition to producing severe nociceptive pain, contributes to the process of lumbosacral deafferentation. The clinical presentation, diagnosis and strategies of management of MPS are discussed.Keywords
This publication has 25 references indexed in Scilit:
- Combined neurogenic and nociceptive pain in a patient with Pancoast tumor managed by epidural hydromorphone and oral carbamazepinePain, 1989
- Practical Aspects of Pain Control In the Patient with CancerCA: A Cancer Journal for Clinicians, 1988
- Biobehavioral factors in cancer painPain, 1988
- Lack of analgesic effect of opioids on neuropathic and idiopathic forms of painPain, 1988
- BACK PAIN—A PRESENTATION OF METASTATIC TESTICULAR GERM CELL TUMOURSThe Lancet, 1987
- Continuous intrathecal hydromorphone and clonidine for intractable cancer painJournal of Neurosurgery, 1986
- Referred pain from intraneural stimulation of muscle fascicles in the median nervePain, 1984
- Pain in far-advanced cancerPain, 1982
- Pain in Malignant Disease of the Uterus1951
- THE PATHWAYS AND RELIEF OF PAIN IN ADVANCED CARCINOMA OF THE CERVIX UTERIThe Lancet, 1937